These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples. Cloos J, Goemans BF, Hess CJ, van Oostveen JW, Waisfisz Q, Corthals S, de Lange D, Boeckx N, Hählen K, Reinhardt D, Creutzig U, Schuurhuis GJ, Zwaan ChM, Kaspers GJ. Leukemia; 2006 Jul; 20(7):1217-20. PubMed ID: 16642044 [Abstract] [Full Text] [Related]
3. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance]. Wang YG, Liu XH, Liang Y, Jin J. Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010 [Abstract] [Full Text] [Related]
4. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia. Scholl S, Theuer C, Scheble V, Kunert C, Heller A, Mügge LO, Fricke HJ, Höffken K, Wedding U. Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718 [Abstract] [Full Text] [Related]
5. Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis. Brunet S, Labopin M, Esteve J, Cornelissen J, Socié G, Iori AP, Verdonck LF, Volin L, Gratwohl A, Sierra J, Mohty M, Rocha V. J Clin Oncol; 2012 Mar 01; 30(7):735-41. PubMed ID: 22291086 [Abstract] [Full Text] [Related]
6. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H, German-Austrian Acute Myeloid Leukemia Study Group. N Engl J Med; 2008 May 01; 358(18):1909-18. PubMed ID: 18450602 [Abstract] [Full Text] [Related]
9. Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3. Lin PH, Lin CC, Yang HI, Li LY, Bai LY, Chiu CF, Liao YM, Lin CY, Hsieh CY, Lin CY, Ho CM, Yang SF, Peng CT, Tsai FJ, Yeh SP. Leuk Res; 2013 Mar 01; 37(3):287-92. PubMed ID: 23276395 [Abstract] [Full Text] [Related]
16. Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD. Labouré G, Dulucq S, Labopin M, Tabrizi R, Guérin E, Pigneux A, Lafarge X, Leguay T, Bouabdallah K, Dilhuydy MS, Duclos C, Lascaux A, Marit G, Mahon FX, Boiron JM, Milpied N, Vigouroux S. Biol Blood Marrow Transplant; 2012 Dec 01; 18(12):1845-50. PubMed ID: 22766221 [Abstract] [Full Text] [Related]
17. Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS study. Guièze R, Cornillet-Lefebvre P, Lioure B, Blanchet O, Pigneux A, Recher C, Bonmati C, Fegueux N, Bulabois CE, Bouscary D, Vey N, Delain M, Turlure P, Himberlin C, Harousseau JL, Dreyfus F, Béné MC, Ifrah N, Chevallier P, GOELAMS. Am J Hematol; 2012 Dec 01; 87(12):1052-6. PubMed ID: 22911473 [Abstract] [Full Text] [Related]
18. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH, Liu HC, Chang WH. Cancer; 2002 Jun 15; 94(12):3292-8. PubMed ID: 12115363 [Abstract] [Full Text] [Related]
20. Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy. Tiesmeier J, Müller-Tidow C, Westermann A, Czwalinna A, Hoffmann M, Krauter J, Heil G, Ganser A, Serve H, Verbeek W. Leuk Res; 2004 Oct 15; 28(10):1069-74. PubMed ID: 15289019 [Abstract] [Full Text] [Related] Page: [Next] [New Search]